“Researchers found no link between taking aspirin and improved breast cancer outcomes, however the drug’s effect on breast density may help with earlier diagnosis, according to two new studies presented at a conference on breast cancer.
“Several studies have shown aspirin to cut the risk of colorectal, breast and other cancers.
“Researchers from the University of Pennsylvania presented the new studies at the San Antonio Breast Cancer Symposium.
” ‘Past studies have found that aspirin may hold anti-cancer benefits. However, many of them were preliminary, preclinical, and didn’t support a clear mortality benefit. They also didn’t look at prior use of aspirin,’ said Dr. Julia Tchou, an associate professor of surgery at the University of Pennsylvania, in a press release. ‘Our data did not support the notion that this century-old pill has protective qualities and down-the-road benefits for breast cancer patients. However, larger patient cohort studies are needed to confirm our results.’ “
“Hypercalcaemia is the most common metabolic disorder associated with cancer, occurring in 10 to 20 per cent of people with cancer. While its connection to cancer is well known, this study has, for the first time, shown that often it can predate the diagnosis of cancer in primary care.
“A simple blood test could identify those with hypercalcaemia, prompting doctors to investigate further.
“The research, published in the British Journal of Cancer, analysed the electronic records of 54,000 patients who had elevated levels of calcium and looked at how many of them went on to receive a cancer diagnosis.
“Dr Fergus Hamilton, who led the research from the Centre for Academic Primary Care at the University of Bristol, said: ‘All previous studies on hypercalcaemia and cancer had been carried out with patients who had already been diagnosed with cancer – hypercalcaemia was seen as a late effect of the cancer.’ “